Choose Myself (Before) Losing Myself
Official title: Choose Myself (Before) Losing Myself: Providing Educational Information to Empower Alzheimer's Dementia Patients and Their Caregivers Utilizing Gamification Techniques Such as Choose Your Own Adventure.
Run by The Cleveland Clinic · NCT07846566 · Data updated 2026-11-12
We’re testing an educational interactive booklet to help people with dementia or memory problems think about future medical decisions and start conversations with family or caregivers.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 25 (estimated) |
| Sponsor | The Cleveland Clinic Academic / other |
| Locations | 1 site (Cleveland, Ohio) |
| Status | Recruiting |
| Started | October 9, 2026 |
| Main results expected | May 30, 2027 |
| Study ends | July 31, 2027 |
| Registry record updated | October 22, 2026 |
| Trial ID | NCT07846566 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 18 or older with mild cognitive impairment or early Alzheimer's disease criteria who can read English and are able to discuss their care preferences with family or caregivers.
✕Probably not a fit
Individuals who lack the decisional capacity or have conditions making participation burdensome may not benefit from the study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study uses a patient-facing CYOA booklet designed to explain how dementia progresses over time. Adults diagnosed with mild cognitive impairment or early Alzheimer’s-related conditions will read the booklet and complete questions in English. The goal is to see if the booklet helps patients consider future medical decisions and discuss their preferences with loved ones or caregivers. The study is conducted at the Cleveland Clinic in Ohio and involves participants who can read and respond to English-language materials. No other sites or collaborators are listed.
Why it matters
Potential benefit: If successful, participants may feel more prepared to discuss and document their future medical care preferences.
How similar studies have gone: This approach is exploratory and educational tools have shown potential in supporting advance care planning in dementia, but results may vary and this exact booklet method is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants are at least 18 years of age * Patients including those: newly diagnosed (within 30 days of informed consent discussion) and established patients diagnosed with mild cognitive impairment or clinical suspicion of mild Alzheimer's dementia diagnosis based on Montreal Cognitive Assessment score (MoCA): 14+, Mini Mental State Exam (MMSE) score: 21+ or Functional Assessment Staging Toll (FAST) score: 1-4 * Able to read and respond to questions in English (workbook is not available in any other language and survey instruments are validated in English language). Exclusion Criteria: * Individuals who lack decisional capacity * Individuals who possess comorbid conditions that, in the opinion of the investigator, would place unnecessary additional burden upon a patient for study participation or patients for whom participation the study would not be in their best interests.
Where it's running
-
The Cleveland Clinic
Cleveland, Ohio, United States Recruiting
Study contacts
- Principal investigator: Kimberlee Fong, DO — The Cleveland Clinic
- Study coordinator: Holly Renner, RN
- Email: rennerh2@ccf.org
- Phone: 2162999529
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
Using Wearables to Find Clues About Mild Cognitive Impairment and Early Alzheimer’s
Researchers are testing whether wearable devices worn in daily life can help identify people 65 and older who might have mild cognitive impairment or early Alzheimer’s disease.
-
VR pupillometry to detect cognitive impairment
This project will try VR-based eye-tracking pupillometry to see if pupil responses can detect and track cognitive problems in adults with Alzheimer's, mild cognitive impairment, depression-related cognitive impairment, or no cognitive issues.
-
PET scan to image PDE4B in people with Alzheimer’s disease or mild cognitive impairment
We will test whether a new PET tracer can measure PDE4B levels in the brains of people aged 50 and older with Alzheimer's or mild cognitive impairment compared with healthy volunteers.
-
Investigating biomarkers related to Alzheimer's disease and cognitive impairment
This study is trying to see how blood tests and brain scans relate to Alzheimer's disease and memory issues in older adults aged 60 to 90.
-
Time-restricted eating intervention for Alzheimer's disease
This study is testing if eating only during a 14-hour window at night can help people with Mild Cognitive Impairment or early Alzheimer's disease think better and sleep more soundly.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.